MedPath

Effect of Stellate Nerve Block in Dysphagia

Not Applicable
Completed
Conditions
Dysphagia
Interventions
Procedure: Injection
Behavioral: placebo
Behavioral: Comprehensive therapy
Registration Number
NCT06335316
Lead Sponsor
Copka Sonpashan
Brief Summary

This is a randomized controlled study, including dysphagic patients with bulbar palsy after ischemic stroke who were received in the department of rehabilitation medicine in China. Both groups were provided with comprehensive rehabilitation including routine rehabilitation and swallowing function training. Besides, the observation group additionally underwent the stellate ganglion block (SGB). At admission and after 20-day treatment,Yale Pharyngeal Residue Severity Rating Scale, video fluoroscopic swallowing study (VFSS), Functional Oral Intake Scale, and penetration-aspiration scale (PAS) were used to assess swallowing function.

Detailed Description

Dysphagia is a frequent and potentially serious complication of stroke. This is a randomized controlled study, including dysphagic patients with bulbar palsy after ischemic stroke who were received in the department of rehabilitation medicine in China. Both groups were provided with comprehensive rehabilitation including routine rehabilitation and swallowing function training. Besides, the observation group additionally underwent the stellate ganglion block (SGB). At admission and after 20-day treatment,Yale Pharyngeal Residue Severity Rating Scale, video fluoroscopic swallowing study (VFSS), Functional Oral Intake Scale, and penetration-aspiration scale (PAS) were used to assess swallowing function.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
122
Inclusion Criteria
  • Diagnosed with ischemic stroke according to the diagnostic criteria, with the stroke occurring in the medulla oblongata and diagnosed as bulbar palsy.
  • Dysphagia.
  • Age >18 years.
  • First-time stroke.
  • Steady vital signs,
  • Transferred or admitted to the Department of Rehabilitation Medicine within 15d after onset.
Exclusion Criteria
  • Allergy to Lidocaine injection or vitamin B12 injection;
  • Severe cognitive impairment;
  • Coagulation disorders;
  • Severe dysfunction of organs including heart, lungs, kidney, liver, etc.;
  • Complicated with other neurological diseases;
  • Dysphagia caused by other diseases or reasons.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Stellate Nerve Block+ routine rehabilitation treatmentComprehensive therapyThe patients were given Nerve block and routine rehabilitation treatment for 10 days.
placebo+routine rehabilitation treatmentComprehensive therapyThe patients were given placebo block and routine rehabilitation treatment for 10 days.
Stellate Nerve Block+ routine rehabilitation treatmentInjectionThe patients were given Nerve block and routine rehabilitation treatment for 10 days.
placebo+routine rehabilitation treatmentplaceboThe patients were given placebo block and routine rehabilitation treatment for 10 days.
Stellate Nerve Block+ routine rehabilitation treatmentLidocaine HydrochlorideThe patients were given Nerve block and routine rehabilitation treatment for 10 days.
Primary Outcome Measures
NameTimeMethod
Functional Oral Intake Scaleday 1 and day 10

The Functional Oral Intake Scale (FOIS) is a tool used to assess the level of independence in oral intake for individuals with swallowing difficulties. The scale ranges from Level 1 to Level 7, with higher Levels indicating better swallowing function.

Secondary Outcome Measures
NameTimeMethod
Yale Pharyngeal Residue Severity Rating Scaleday 1 and day 10

The Yale Pharyngeal Residue Severity Rating Scale (Yale) was used to assess the severity of pharyngeal residue in patients. While PAS primarily evaluated whether food or liquid entered the airway, Yale focused on the condition of pharyngeal residue. The scale includes the four levels from 0 to 3, with lower levels indicating less severe pharyngeal residue.

penetration-aspiration scaleday 1 and day 10

this assessment evaluated the patient's swallowing of contrast medium and whether there was retention, penetration, and aspiration. It included multiple items, each with the corresponding criteria, Specifically, whether the swallowed material entered the airway, passed through or contacted the vocal cords, and whether the patient exhibited the corresponding ability to clear. There were 8 levels in the results, with higher levels indicating more severe aspiration.

The Swallowing Quality of Life Questionnaireday 1 and day 10

The Swallowing Quality of Life Questionnaire (SWAL-QOL) is a tool designed to assess how swallowing difficulties impact an individual's quality of life. The questionnaire covers various aspects such as eating, speech, and social interaction to understand the challenges and effects of swallowing disorders on daily life.

SWAL-QOL scores can range from 0 to 100, with higher scores indicating a better quality of life related to swallowing function. Therefore, a higher SWAL-QOL score reflects less negative impact of swallowing difficulties on an individual's overall quality of life, highlighting better adaptation to and management of swallowing issues.

Trial Locations

Locations (1)

Huimin Hos.

🇨🇳

Pengfu, Taiwan

© Copyright 2025. All Rights Reserved by MedPath